… a major leap toward safer cancer treatments, scientists at the Francis Crick … , either alone or alongside existing cancer drugs. A New Era of Targeted … work together to create better cancer treatments.” Dr. Matt Patricelli, Chief Scientific …

… psychotropic drugs, and all anti-cancer drugs. The move is set to … these medications. Vaccines and anti-cancer drugs, for instance, are expensive, life …

Angus Chen covers all issues broadly related to cancer including drugs, policy, science, and equity. He joined STAT in 2021 after covering health and science at NPR and NPR affiliate stations. His work has been recognized by national Edward R. Murrow …

… the "groundbreaking" brain cancer drug for use on the NHS …

MISS MANNERS by Judith Martin, Nicholas Ivor Martin and Jacobina Martin DEAR MISS MANNERS: I have been given a gift of immeasurable proportions: the gift of having my life saved by many nurses and doctors after my cancer diagnosis. I want to show my …

Sponsored Content This story is brought to you by Ochsner Health.At Ochsner Cancer Center of Acadiana, people diagnosed with blood cancers find more than the latest treatments — they also find a village of people ready to help them on their journey back to …

Joe Biden was seen in public for the first time since beginning radiation therapy earlier this month. Last week, a spokesperson for the former president told Politico, “As part of a treatment plan for prostate cancer, President Biden is currently …

… / Flinders University – SWNS Prostate cancer treatment could be “supercharged” by a … enzalutamide – a widely used prostate cancer medication – significantly boosted the treatment’s …

By Mrinalika Roy (Reuters) -AstraZeneca and Daiichi Sankyo’s drug Enhertu has shown strong results in two pivotal studies in the early stage of a certain type of breast cancer, according to data announced on Saturday. The findings from both trials, …

hapabapa Roche (OTCQX:RHHBY) subsidiary Genentech announced on Saturday that its experimental breast cancer therapy, giredestrant, as part of a combination regimen, reduced the risk of disease progression or death in up to 62% of patients in a Phase 3 …